Aytu BioPharma, Inc.

AYTU · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$32,630$30,952$18,173$20,398
Short-Term Investments$0$0$0$0
Receivables$33,225$31,155$35,825$25,403
Inventory$10,100$11,434$11,058$11,085
Other Curr. Assets$5,154$0$0$0
Total Curr. Assets$81,109$79,179$72,512$63,053
Property Plant & Equip (Net)$1,510$1,593$1,657$1,694
Goodwill$0$0$0$0
Intangibles$41,430$42,201$48,711$49,958
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$939$1,204$1,321$1,522
Total NC Assets$43,879$44,998$51,689$53,174
Other Assets$0$0$0$0
Total Assets$124,988$124,177$124,201$116,227
Liabilities
Payables$12,342$10,601$12,041$11,699
Short-Term Debt$1,857$10,920$11,885$5,869
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$51,794$26,145$29,002$16,008
Total Curr. Liab.$65,993$63,064$70,706$64,048
LT Debt$0$10,895$9,535$9,983
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$35,824$30,267$8,061$10,325
Total NC Liab.$35,824$42,147$18,597$21,414
Other Liabilities$0$0$0$0
Cap. Leases$0$1,122$1,103$1,288
Total Liabilities$101,817$105,211$89,303$85,462
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$1$1
Retained Earnings-$331,570-$333,535-$313,717-$317,711
AOCI$0$0$0$0
Other Equity$354,740$0$0$0
Total Equity$23,171$18,966$34,898$30,765
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$124,988$124,177$124,201$116,227
Net Debt-$30,773-$9,137$3,247-$4,546